Showing results (601-610 of 682) with videos related to

Sort By:
Pageof 69
Immunogenetics|November 30, 2019
Nomenclature report for killer-cell immunoglobulin-like receptors (KIR) in macaque species: new genes/alleles, renaming recombinant entities and IPD-NHKIR updatesJesse Bruijnesteijn, Natasja G de Groot, Nel Otting, et al.
Thrombosis and Haemostasis|March 14, 2018
Truncation of ADAMTS13 by Plasmin Enhances Its Activity in PlasmaChantal C Clark, Mirjam M Mebius, Steven de Maat, et al.
The American Journal of Tropical Medicine and Hygiene|March 10, 2009
ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malariaQuirijn de Mast, Evelyn Groot, Puji B Asih, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2009
Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cellsXia V Yang, Yajnavalka Banerjee, José A Fernández, et al.
Thrombosis and Haemostasis|October 2, 2015
Platelet density per monocyte predicts adverse events in patients after percutaneous coronary interventionBert Rutten, Mark Roest, Elizabeth A McClellan, et al.
Journal of Thrombosis and Haemostasis : JTH|February 18, 2010
von Willebrand factor activation, granzyme-B and thrombocytopenia in meningococcal diseaseM J Hollestelle, T Sprong, N Bovenschen, et al.
Blood|December 2, 2010
Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndromeZurina Romay-Penabad, Renan Aguilar-Valenzuela, Rolf T Urbanus, et al.
International Journal of Cardiology|December 7, 2010
β-radiation reduces the reactivity of extracellular matrix proteins in intravascular brachytherapy (IVBT), resulting in decreased platelet adhesionYa Ping Wu, Pieter R Stella, Shuang Feng Chen, et al.
Blood|November 9, 2006
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levelsCarina J M van Schooten, Cécile V Denis, Ton Lisman, et al.
Thrombosis and Haemostasis|June 10, 2011
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary interventionJanine E van Loon, Peter P T de Jaegere, Hans Ulrichts, et al.
Pageof 69